Delivery Order SPE2DB24D2208-SPE2DB24FHHDY

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick injector pens. The contract has a ceiling value of $2,969.96 and an ultimate completion date of April 5, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $9,151.98 firm-fixed-price delivery order is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injector pens. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Repatha (140 mg/mL) SureClick injector pens, a specialty medication for the treatment of high cholesterol. The contract has a ceiling value of $1,016.82 and a completion date of September 16, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. This contract is likely part...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,777.43 firm-fixed-price contract is for the supply of Repatha (evolocumab) 140mg/ml SureClick injectors. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order falls under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,932.68, is for the supply of Repatha 140 mg/mL SureClick injector pens. The contract has an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this contract. The company also holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injector pens. The contract has a ceiling value of $1,660.96 and a performance period ending on May 9, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick syringes. The ceiling value of the contract is $1,016.82, with a period of performance through August 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide this specialty medication to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL Sureclick injector pens. The contract has a firm fixed price of $3,899.04 and an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical specialty medication products to support medical treatment programs and healthcare facilities serving the U.S. military and other federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (140 mg/mL SureClick) medication. The contract has a ceiling value of $2,103.96 and a period of performance through February 18, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha 140 mg/mL SureClick injection medication. The contract has a firm fixed price of $1,098.00 and a period of performance through April 17, 2025. The contract is not set aside and allows for the delivery of a range of pharmaceutical products to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB24FHHDY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha (evolocumab) 140 mg/mL SureClick injector pens. The contract has a ceiling value of $9,034.31 and an ultimate completion date of September 4, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen is the prime contractor and will be responsible for supplying this specialty medication to support various government healthcare programs and facilities, including military treatment centers. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a wide range of pharmaceutical and medical supplies from the contractor.

Generated 12/3/24, 9:47 AM